TAK — Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) price, chart and key statistics

Price data

Price

$18.19

Change YTD

+16.68%

Next earnings

Oct 29, 2026

Market cap

57.3B2017-03 37.4B2026-09 57.3B+53.4% over the window

Enterprise value

81.1B

Shares outstanding

3.2B2017-03 1.6B2026-03 3.2B+99.2% over the window

52W low

$12.99

52W high

$19.10

From 52W high

-4.76%

From 52W low

+40.03%

52W range

85%

Beta

-0.08

Volume

Rel volume

0.93×

30D volume

2.2M

30D $ vol

41.1M

Fundamentals

Sales (ttm)

29.8B2017-03 16B2026-03 29.8B+86.4% over the window

Sales/share

$9.462017-03 $10.112026-03 $9.46-6.4% over the window

EPS (ttm)

-$0.322017-03 $0.672026-03 -$0.32-147.4% over the window

FCF (ttm)

6.9B

FCF/share

$2.19

Book value/share

$14.862017-03 $11.072026-03 $14.86+34.3% over the window

Net margin

-3.38%2017-03 6.7%2026-03 -3.4%-150.6% over the window

ROE

-2.15%2017-03 6.1%2026-03 -2.1%-135.3% over the window

ROA

-1.03%2018-03 4.4%2026-03 -1.0%-123.6% over the window

Debt / equity

0.59×2018-03 0.492026-03 0.59+19.2% over the window

Current ratio

1.092018-03 1.462026-03 1.09-25.4% over the window

Growth (CAGR, ttm) · 10Y

Sales

-0.86%2025-03-31 → 2026-03-3130B → 29.8B (-0.9% total)+0.05%2023-03-31 → 2026-03-3129.7B → 29.8B (+0.2% total)-0.25%2021-03-31 → 2026-03-3130.2B → 29.8B (-1.3% total)n/a

Shares

-1.00%2025-03-31 → 2026-03-313.2B → 3.2B (-1.0% total)-0.15%2023-03-31 → 2026-03-313.2B → 3.2B (-0.5% total)-0.02%2021-03-31 → 2026-03-313.2B → 3.2B (-0.1% total)n/a

Per-share growth (CAGR, ttm) · 10Y

Sales/share

+0.14%2025-03-31 → 2026-03-31$9.44 → $9.46 (+0.1% total)+0.20%2023-03-31 → 2026-03-31$9.40 → $9.46 (+0.6% total)-0.24%2021-03-31 → 2026-03-31$9.57 → $9.46 (-1.2% total)n/a

Book value/share

+2.24%2025-03-31 → 2026-03-31$14.53 → $14.86 (+2.2% total)-0.62%2023-03-31 → 2026-03-31$15.14 → $14.86 (-1.9% total)-0.01%2021-03-31 → 2026-03-31$14.87 → $14.86 (-0.1% total)n/a

Dividend/share

+4.98%2025-03-31 → 2026-03-31$0.62 → $0.66 (+5.0% total)+0.33%2023-03-31 → 2026-03-31$0.65 → $0.66 (+1.0% total)-5.03%2021-03-31 → 2026-03-31$0.85 → $0.66 (-22.8% total)n/a

Price

+24.27%2025-09-30 → 2026-09-30$14.64 → $18.19 (+24.2% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+5.54%2023-09-29 → 2026-09-30$15.47 → $18.19 (+17.6% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+2.12%2021-09-30 → 2026-09-30$16.38 → $18.19 (+11.1% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.-2.66%2016-09-29 → 2026-09-30$23.83 → $18.19 (-23.7% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.

Total return

+24.27%2025-09-30 → 2026-09-30$14.64 → $18.19 (+24.2% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+7.88%2023-09-29 → 2026-09-30$14.48 → $18.19 (+25.6% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+4.47%2021-09-30 → 2026-09-30$14.62 → $18.19 (+24.5% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+0.50%2016-09-29 → 2026-09-30$17.31 → $18.19 (+5.1% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)Price ÷ TTM diluted EPS. Net income carries everything below the operating line, including one-off gains. Negative when the trailing year lost money.

-56.9×2017-03 35.072026-09 -56.99-262.5% over the window

P/OI (ttm)Price ÷ TTM operating income. Excludes the below-the-line items that make P/E jump — mark-to-market gains, settlements, tax true-ups.

1394.6×2017-03 25.992026-09 1394.59+5265.6% over the window

Fwd P/E

35.6×

P/S (ttm)Market cap ÷ TTM revenue.

1.9×2017-03 2.342026-09 1.92-17.7% over the window

P/B (mrq)Market cap ÷ stockholders' equity at the most recent quarter end.

1.2×2017-03 2.142026-09 1.22-42.7% over the window

P/FCF (ttm)Market cap ÷ TTM free cash flow (operating cash flow − capex).

8.3×

EV/EBITDA (fy)

16.9×

EV/Sales (ttm)

2.7×

FCF yield (ttm)TTM free cash flow ÷ market cap — the inverse of P/FCF.

12.01%

Dividend yield (fwd)Indicated forward annual dividend ÷ current price — the rate the company has announced, not what was actually paid over the past year.

3.61%

Dividend/share (fwd)

$0.66

Buyback yield (cash, ttm)Buybacks net of issuance over the trailing twelve months ($333.5M) ÷ today's market cap ($57.3B). Dollars SPENT over what the company is worth NOW — a stock that fell after buying reads high.

0.58%2017-03 0.5%2026-03 0.6%+4.1% over the window

Shareholder yield (cash, ttm)(TTM buybacks net of issuance $333.5M + TTM dividends $2.1B) ÷ today's market cap ($57.3B). Same caveat as the cash buyback yield.

4.19%2017-03 4.1%2026-03 4.1%+0.4% over the window

Vs own 10Y history

P/E

88th

P/OI

99th

P/S

66th

P/B

64th